OUR EXPERTISE

Featured Publications & Presentations

  1. Popovian, Robert and Winegarden, Wayne, An Estimate of the Net Benefits from Prior Authorization Policies in the U.S., Vol. 15 No. 4: 833. Health Science Journal, https://www.hsj.gr/medicine/an-estimate-of-the-net-benefits-from-prior-authorization-policies-in-the-us.pdf
  2. We Need Greater Transparency to Improve the U.S. Healthcare System, InsideSources https://insidesources.com/we-need-greater-transparency-to-improve-the-u-s-healthcare-system/
  3. Winegarden, Wayne and Popovian, Robert, Reforming Rebate Contracting will Improve Drug Affordability, Vol. 14 No. 7: 783, Health Science Journal https://www.hsj.gr/medicine/reforming-rebate-contracting-willimprove-drug-affordability.php?aid=34290
  4. Blurring the Lines between Medical Practice and Insurance Coverage. Healthcare Business Today, April 2021. https://www.healthcarebusinesstoday.com/blurring-the-lines-between-medical-practice-and-insurance-coverage/
  5. Podcast, Debunking the Myth of Who Funds Biomedical Innovation, Ideagen, https://www.youtube.com/watch?v=FdhNBoxgc8U
  6. Podcast, Drug Pricing Reforms, Good and Bad Ideas with Dr. Robert Popovian, The American Consumer Institute, https://open.spotify.com/episode/02dbUcKWwQBn06OacxxmRv
Morning Consult Opinion Editorials

Other Publications
  • Dranitsaris G, Jacobs I, Kirchhoff C, Popovian R, Shane LG. Drug tendering: drug supply and shortage implications for the uptake of biosimilars. September 29, 2017. Clinical Economics and Outcomes Research, https://www.ncbi.nlm.nih.gov/pubmed/29033595 
  • Cohen Hillel, Beydoun Donna, Chien David, Lessor Tracy, McCabe Dorothy, Muenzberg Michael, Popovian Robert and Uy Jonathan. Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physician. Advances In Therapy. January 2017, Volume 33, Issue 12, pp 2160–2172 
  • Nichol MB, Shi S, Knight TK, Popovian R, and Morita R. Impact of Market Forces on Statin persistence patterns in a California Medicaid population. Value In Health. 2004, Vol 7, No 3, page 334. 
  • Setter SM, Corbett C, Gates, B, Terriff C, Johns CA, Sclar DA, and Popovian R. Nonsteriodal Anti-inflammatory Drugs: The Need for Assessment and Education. Home Care Provider. 2001, VOL 6; PART 3, pages 100-105. 
  • Setter SM, Corbett CF, Terriff CM, Gates BJ, Johns C, Broemeling L, Maccini D and Popovian R. Abstract – Knowledge of nonsteroidal anti-inflammatory drugs in at risk elders: effectiveness of individualized patient education. Pharmacotherapy. Volume 20 (10), 2000, page 1229. 
  • Gerding, G, Carlson, J, Carter, C, Doak, M, Frederick, K and Popovian, R. Abstract – Treatment of Osteoarthritis and Rheumatoid Arthritis in a Long-term Care Setting. The Consultant Pharmacist. Volume 15 (9), 2000, page 933. 
  • Johnson, KA, Nichol MB, Popovian R and Liu G. Letter to the Editor: The Impact of Pharmaceutical Capitation to Primary Medical Groups on the Health Care Expenditures of Medicare HMO Enrollees. Journal of Managed Care Pharmacy. Volume 6 (1), January/February 2000, pages 8-9. 
  • Popovian R, Johnson, KA, Nichol MB and Liu G. The Impact of Pharmaceutical Capitation of Primary Medical Groups on the Health Care Expenditures of Medicare HMO Enrollees. Journal of Managed Care Pharmacy. Volume 5 (5), September/October 1999, pages 414-419. 
  • Niedermann MS, McCombs JS, Unger AN, Kumar A and Popovian R. Treatment cost of acute exacerbations of chronic bronchitis. Clinical Therapeutics. Volume 21 (3), March 1999 1998, pages 576-591. 
  • Niedermann MS, McCombs JS, Unger AN, Kumar A and Popovian R. The Cost of Treating Community Acquired Pneumonia. Clinical Therapeutics. Volume 20 (4), July/August 1998, pages 820-837.  
  • Popovian R, Hay, JW, Sung JCY and Jaresko GS,. Cost-effectiveness analyses of penicillin prophylaxis in dental procedures for prevention of infective endocarditis in mitral valve prolapse patients. Pharmacotherapy. Volume 17 (1), 1997, page 192. 
  • Milliman & Robertson, Inc.. Contributor to the publication – Healthcare Management Guidelines, Volume 5, Primary and Pharmaceutical Care. 1996. 
  • Jaresko GS, Sung JC, Tajbakhsh-Werner G, Popovian R and Goldshtein G. Implementing an Interdisciplinary, pharmacy directed Enterobactor surveillance program. International Pharmaceutical Abstracts. Volume 33 (21), 1996, page 2245. 
  • Jaresko GS, Popovian R, Nichol MB and Riley S. Factors influencing outcomes in patients with type I -lactamase producing gram negative bacteremia. Pharmacotherapy. Volume 15 (1), 1995, page 113. 
  • Popovian R, Bedikian A, Gill MA. Management of Diabetic Foot Ulcers. California Pharmacist. February 1993, pages 28-35. 
Presentation Highlights
  • NORD (National Organization of Rare Diseases) Summit, The Time is Now: Addressing Affordability While Sustaining Innovation 
  • Financial Times, Financial Pressures and Healthcare Reform, September 2018 
  • FDA/CMS Summit, Obstacles, Reimbursement, and Leverage Opportunities for Boosting Competition and Adoption of Biosimilars in US Market, December 2017 
  • Sino-American Biotechnology and Pharmaceutical Professional Association, Market Based Solutions in Making Medicines Affordable, Lowering Healthcare Costs and Protecting Biopharmaceutical Innovation, June 2017 
  • Texas Healthcare and Biosciences Summit: Value of Innovation and Drug Development, 2016, 2017, 2018 and 2019 
  • Deloitte Center for Health Solutions and The Network for Excellence in Health Innovatio: Delivering medical innovation In a Value Based World, February 15, 2016 
  • Building a 21st Century Health Care System: Aligning Policy, Accelerating Cures, Delivering Hope, August 2014, Using Data to Support Patient Centered Innovation – Manhattan Institute and Tufts School of Medicine 
  • Connected Health, Better Adherence – NEHI, Prescription for Better Health and PhRMA, Jan 2014, The Future: How should we shape health IT policy to support proper medication use and improved adherence? 
  • American Association of Colleges of Pharmacy, 2011 Annual Meeting, US Policies Surrounding Pharmaceutical Innovation 
  • Academic & Industry Intersection Conference: Profiles of Success, Georgia BIO and Emory University, 2011, Future of Industry and Physician Relations “Our Path Forward” 
  • Minnesota Physician Publishing, 2009, Health care reform panel discussion 
  • American Psychiatric Association, Annual Meeting, 2005, Promises and Politics of Evidence-Based Medicine